Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of the Vapor Nanobubble Technology (MalariSense) for Malaria Diagnostics

NCT02672228 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT02672228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02672228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of the Vapor Nanobubble Technology (MalariSense) for Malaria Diagnostics
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
December 31, 2015
Enrollment
208 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria